DarioHealth Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.8% | +59.2% | +8.6% | +18.7% | +2.4% | -11.2% | -20.5% | -6.7% | +4.5% | +6.7% | -7.3% | – | |
| – | -18.2% | +39.8% | -31.9% | -2.8% | -4.0% | +35.8% | -31.3% | +1.0% | +43.6% | -16.6% | -16.7% | – | |
| – | +102.8% | +96.6% | +64.0% | +30.9% | +5.2% | -29.3% | -12.5% | -11.2% | -21.4% | +35.0% | -0.2% | – | |
| – | -25.9% | +58.3% | +2.5% | -20.0% | -3.0% | -22.2% | -9.4% | -10.6% | -20.9% | -9.5% | -11.9% | – | |
| – | +30.8% | +24.7% | -25.7% | -25.5% | +14.9% | -22.8% | -3.0% | +42.2% | -10.2% | -21.4% | -19.4% | – | |
| – | – | – | – | – | – | – | – | – | +285.2% | -78.2% | -8.0% | – | |
| – | -8.6% | +25.6% | -9.3% | -25.7% | -3.0% | -19.4% | -2.2% | -203.1% | – | – | – | – | |
| – | +2,321.7% | -97.1% | +81.3% | +0.0% | -24.1% | +54.5% | -8.8% | +3,725.8% | +77.7% | -44.4% | -4.2% | – | |
| – | – | – | – | – | – | – | – | – | – | -108.7% | – | – | |
| – | – | -3,215.6% | – | – | – | -85.8% | – | – | – | – | +475.4% | – | |
| – | – | – | – | – | – | – | – | – | – | -109.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.